Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Microtubule dynamics machinery" does not refer to a single molecular target or protein but rather encompasses the collective system responsible for the regulation of microtubule assembly and disassembly within eukaryotic cells. This includes α/β-tubulin heterodimers that form the core structure of microtubules, as well as a wide array of associated proteins such as motor proteins (e.g., kinesins, dyneins) and plus-end tracking proteins (+TIPs), which modulate dynamic instability—the rapid switching between growth and shrinkage phases essential for cellular processes like mitosis, migration, intracellular trafficking, and maintenance of cell shape[1][4][5]. The "machinery" also includes regulatory pathways involving GTP hydrolysis at tubulin subunits[6], post-translational modifications[7], and interactions with small molecules or drugs. Because this is not a specific molecule but rather an ensemble concept describing a functional network or process in cell biology, it is **not considered a canonical therapeutic target** in itself. However, many components within this system—most notably tubulin itself—are validated drug targets for anti-cancer agents such as paclitaxel and vincristine that disrupt microtubule dynamics to inhibit cell division[5][7]. **In summary:** "Microtubule dynamics machinery" is too broad to be classified as an individual molecular target; it refers instead to the integrated set of molecules controlling microtubule behavior. For structured data purposes requiring specificity at the level of gene/protein/receptor/enzyme/etc., this entry should be flagged as incorrect or insufficiently specific.
Drugs interacting with the microtubule dynamics machinery exert their effects primarily through the stabilization of microtubules (preventing depolymerization) or the destabilization of microtubules (promoting depolymerization).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule dynamics machinery.